GEVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Synageva BioPharma Corp's other income expense for the three months ended in Mar. 2015 was $-0.25 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2015 was $-0.39 Mil.
Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.
Synageva BioPharma Corp Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2015 was -0.00899999999999 (Jun. 2014 ) + -0.265 (Sep. 2014 ) + 0.131 (Dec. 2014 ) + -0.252 (Mar. 2015 ) = $-0.39 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.
Synageva BioPharma Corp Annual Data
Synageva BioPharma Corp Quarterly Data